In comparison, conventional myeloid derived POWER (cDC), recognized as HLA-DR+ CD11c+ amongst non-lymphoid cells, are not significantly improved or reduced during possibly the incubation period and also the early stage of PURPOSE (Fig 3D)

In comparison, conventional myeloid derived POWER (cDC), recognized as HLA-DR+ CD11c+ amongst non-lymphoid cells, are not significantly improved or reduced during possibly the incubation period…